http://rdf.ncbi.nlm.nih.gov/pubchem/reference/26405506

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, Non-U.S. Gov't|Review
issn 1939-5116
1939-0041
issueIdentifier 5
pageRange e1557-
publicationName Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology
startingPage e1557
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_d0619506276d346311b19a04f792ec36
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_c9715a34c9ccde7ccc72cadee3277b94
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_337bdbc95beda6e20a5a1e4db96ca209
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_21a30339bae3a924a4fae709a0a2f262
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_5d3cd3d96f77cd572b635abad5170178
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_71a1cf481940e0b159dda9b1dfb5bcff
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_ee23a7bbb0ac778dc7397b8ef5e5ef6e
bibliographicCitation McBride DA, Kerr MD, Wai SL, Shah NJ. Applications of molecular engineering in T-cell-based immunotherapies. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2019 Sep;11(5):e1557. PMID: 30972976; PMCID: PMC7869905.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4ad7c7e888f8d158ced2ee22f6b31d2b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7a2d3d0f619bda215e605c36efa21a7a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-1727-5732
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e97318bb7da1aa3e4adb46a6f4421b93
date 2019-04-10^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/30972976
https://doi.org/10.1002/wnan.1557
https://pubmed.ncbi.nlm.nih.gov/PMC7869905
isPartOf https://portal.issn.org/resource/ISSN/1939-0041
https://portal.issn.org/resource/ISSN/1939-5116
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/36716
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Applications of molecular engineering in T‐cell‐based immunotherapies
discusses http://id.nlm.nih.gov/mesh/M0001407
http://id.nlm.nih.gov/mesh/M000638845
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D007167
http://id.nlm.nih.gov/mesh/D013601Q000276
http://id.nlm.nih.gov/mesh/D005818
hasSubjectTerm http://id.nlm.nih.gov/mesh/D006412Q000378
http://id.nlm.nih.gov/mesh/D000941Q000378
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D000818
http://id.nlm.nih.gov/mesh/D000076962Q000378
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7317

Showing number of triples: 1 to 43 of 43.